Curcumin delays development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors

Menopause

Volumn 17, Issue 1, 2010, Pages 178-184

  Carroll, Candace E ^a   Benakanakere, Indira ^b   Besch Williford, Cynthia ^a   Ellersieck, Mark R ^c   Hyder, Salman M ^a  

^a Department of Biomedical Sciences ^*  (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

(7, 12 Dimethylbenz a anthracene); Breast cancer; Curcumin; Progestins; Vascular endothelial growth factor

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CURCUMIN; ESTROGEN RECEPTOR; MEDROXYPROGESTERONE ACETATE; PROGESTERONE RECEPTOR; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER INCIDENCE; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; NONHUMAN; RAT;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTINEOPLASTIC AGENTS; CURCUMIN; DIETARY SUPPLEMENTS; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MEDROXYPROGESTERONE ACETATE; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 74549219394     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181afcce5     Document Type: Article

References (24)

1. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestins in healthy postmenopausal women: principle results from the Women's Health Initiative randomized control trial. JAMA 2002;288:321-333.
2. Benakanakere I, Williford CB, Schnell J, et al. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats. Clin Cancer Res 2006;12:4062-4071.
3. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy post-menopausal women: the Women's Health Initiative randomized trial. JAMA 2003;289:3243-3253.
4. Liang Y, Besch-Williford C, Brekken RA, Hyder SM. Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating anti-tumor therapeutics. Cancer Res 2007;67:9929-9936.
5. Hyder SM, Murthy L, Stancel GM. Progestin regulation of vascular endothelial growth factor in human breast cancer cells. Cancer Res 1998;58:392-395. (Pubitemid 28087395)
6. Liang Y, Hyder SM. Proliferation of endothelial and tumor epithelial cells by progestin-induced VEGF from human breast cancer cells: paracrine and autocrine effects. Endocrinology 2005;146:3632-3641.
7. Liang Y, Besch-Williford C, Benakanakere I, Hyder SM. Re-activation of p53 pathway inhibits in vivo and in vitro growth of hormone-dependent human breast cancer cells. Int J Oncol 2007;31:777-784.
8. Hamdy RC. Women's Health Initiative study. South Med J 2002;95: 951-965.
9. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci 2006;78:2081-2087.
10. Lin YG, Kunnumakkara AB, Nair A, et al. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-JB pathway. Clin Cancer Res 2007;13:3423-3430.
11. Zava DT, Dollbaum CM, Blen M. Estrogen and progestin bioactivity of foods, herbs, and spices. Proc Soc Exp Biol Med 1998;217:369-378.
12. Verma SP, Goldin BR, Lin PS. The inhibition of the estrogen effects of pesticides and environmental chemicals by curcumin and isoflavonoids. Environ Health Prospect 1998;106:807-812.
13. Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001;21:2895-2900.
14. Carroll CE, Ellersieck MR, Hyder SM. Curcumin inhibits MPA-induced secretion of VEGF from T47-D human breast cancer cells. Menopause 2008;15:570-574.
15. Singletary K, MacDonald C, Wallig M, Fisher C. Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)Yinduced mammary tumorigenesis and SMBA-DNA adduct formation by curcumin. Cancer Lett 1996;106: 137-141.
16. Russo J, Russo IH. Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol Neoplasia 2000;5:187-200.
17. Nardulli AM, Greene GL, O'Malley BW, Katzenellenbogen BS. Regulation of progesterone receptor message ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation. Endocrinology 1988;122:935-944.
18. Read LD, Snider CE, Miller JS, Greene GL, Katzenellenbogen BS. Ligand-modulated regulation of progesterone receptor messenger ribo-nucleic acid and protein in human breast cancer cell lines. Mol Endocrinol 1988;2:263-271.
19. Choudhuri T, Pal S, Das T, Sa G. Curcumin selectively induces apoptosis in deregulated cyclin D1Yexpressed cells at G2 phase of cell cycle in a p53-dependent manner. J Biol Chem 2005;280:20059-20068.
20. Shanker S, Ganapathy S, Chen Q, Srivastave RK. Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis. Mol Cancer 2008;7:16.
21. Huang S, Robinson JB, DeGuzman A, Bucana CD, Fidler IJ. Blockade of nuclear factor-JB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing of vascular endothelial growth factor and interleukin 8. Cancer Res 2000;60:5334-5339.
22. Shibata A, Nagaya T, Imai T, Funahashi H, Nakao A, Seo H. Inhibition of NF-JB activity decreases the VEGF mRNA expression in MDA-MB-231. Breast Cancer Res Treat 2002;73:237-243.
23. Bachmeier BE, Nerlich AG, Iancu CM, et al. The chemopreventive polyphenol curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol Biochem 2007;19:137-152.
24. Roger P, Sahla ME, Mäkelä S, Gustafsson JA, Baldet P, Rochefort H. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 2001;61:2537-2541.